These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 30565819)

  • 1. Impact of haemoglobin A1c trajectories on chronic kidney disease progression in type 2 diabetes.
    Low S; Zhang X; Wang J; Yeoh LY; Liu YL; Ang SF; Subramaniam T; Sum CF; Lim SC
    Nephrology (Carlton); 2019 Oct; 24(10):1026-1032. PubMed ID: 30565819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carotid Intima-Media Thickness and Visit-to-Visit HbA1c Variability Predict Progression of Chronic Kidney Disease in Type 2 Diabetic Patients with Preserved Kidney Function.
    Takenouchi A; Tsuboi A; Kurata M; Fukuo K; Kazumi T
    J Diabetes Res; 2016; 2016():3295747. PubMed ID: 28090540
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk association of HbA1c variability with chronic kidney disease and cardiovascular disease in type 2 diabetes: prospective analysis of the Hong Kong Diabetes Registry.
    Luk AO; Ma RC; Lau ES; Yang X; Lau WW; Yu LW; Chow FC; Chan JC; So WY
    Diabetes Metab Res Rev; 2013 Jul; 29(5):384-90. PubMed ID: 23463747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the longitudinal trajectory of urinary albumin/creatinine ratio in diabetic patients with adverse cardiac event risk: a retrospective cohort study.
    Li H; Ren Y; Duan Y; Li P; Bian Y
    Front Endocrinol (Lausanne); 2024; 15():1355149. PubMed ID: 38745945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of HbA
    Lee MY; Huang JC; Chen SC; Chiou HC; Wu PY
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30567403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variability in HbA1c, blood pressure, lipid parameters and serum uric acid, and risk of development of chronic kidney disease in type 2 diabetes.
    Ceriello A; De Cosmo S; Rossi MC; Lucisano G; Genovese S; Pontremoli R; Fioretto P; Giorda C; Pacilli A; Viazzi F; Russo G; Nicolucci A;
    Diabetes Obes Metab; 2017 Nov; 19(11):1570-1578. PubMed ID: 28432733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycemic Control and Adverse Clinical Outcomes in Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus: Results from KNOW-CKD.
    Heo GY; Koh HB; Kim HW; Park JT; Yoo TH; Kang SW; Kim J; Kim SW; Kim YH; Sung SA; Oh KH; Han SH
    Diabetes Metab J; 2023 Jul; 47(4):535-546. PubMed ID: 37096377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cohort study on the correlation between serum uric acid trajectory and the progression of renal function in patients with Type 2 diabetes mellitus.
    Pan J; Yang Q; Peng J; Li A; Liu Y; Yi B
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):725-732. PubMed ID: 37539575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incident Type 2 Diabetes Among Individuals With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Jepson C; Hsu JY; Fischer MJ; Kusek JW; Lash JP; Ricardo AC; Schelling JR; Feldman HI;
    Am J Kidney Dis; 2019 Jan; 73(1):72-81. PubMed ID: 30177484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low serum bilirubin level predicts the development of chronic kidney disease in patients with type 2 diabetes mellitus.
    Ahn KH; Kim SS; Kim WJ; Kim JH; Nam YJ; Park SB; Jeon YK; Kim BH; Kim IJ; Kim YK
    Korean J Intern Med; 2017 Sep; 32(5):875-882. PubMed ID: 28560862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum N-terminal Pro-brain Natriuretic Peptide Level is Associated with the Development of Chronic Kidney Diseases in Patients with Type 2 Diabetes.
    Sawada R; Hashimoto Y; Senmaru T; Tanaka M; Ushigome E; Yamazaki M; Fukui M
    Endocr Metab Immune Disord Drug Targets; 2018; 18(6):590-595. PubMed ID: 29697035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rate of kidney function decline and factors predicting progression of kidney disease in type 2 diabetes mellitus patients with reduced kidney function: A nationwide retrospective cohort study.
    Kaewput W; Thongprayoon C; Chewcharat A; Rangsin R; Satirapoj B; Kaewput C; Suwannahitatorn P; Bathini T; Mao MA; Cato LD; Harrison AM; Vaitla P; Cheungpasitporn W
    Ther Apher Dial; 2020 Dec; 24(6):677-687. PubMed ID: 31997551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor 23 and incident CKD in type 2 diabetes.
    Isakova T; Craven TE; Lee J; Scialla JJ; Xie H; Wahl P; Marcovina SM; Byington RP; Wolf M
    Clin J Am Soc Nephrol; 2015 Jan; 10(1):29-38. PubMed ID: 25343949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term prospective observation suggests that glomerular hyperfiltration is associated with rapid decline in renal filtration function: A multiethnic study.
    Low S; Zhang X; Wang J; Yeoh LY; Liu YL; Ang KKL; Tang WE; Kwan PY; Tavintharan S; Sum CF; Lim SC
    Diab Vasc Dis Res; 2018 Sep; 15(5):417-423. PubMed ID: 29807475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes Control and the Risks of ESRD and Mortality in Patients With CKD.
    Navaneethan SD; Schold JD; Jolly SE; Arrigain S; Winkelmayer WC; Nally JV
    Am J Kidney Dis; 2017 Aug; 70(2):191-198. PubMed ID: 28196649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycated Hemoglobin Level and Mortality in a Nondiabetic Population with CKD.
    Trivin C; Metzger M; Haymann JP; Boffa JJ; Flamant M; Vrtovsnik F; Houillier P; Stengel B; Thervet E;
    Clin J Am Soc Nephrol; 2015 Jun; 10(6):957-64. PubMed ID: 25979978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of long-term glycemic variability on estimated glomerular filtration rate decline among patients with type 2 diabetes mellitus: Insights from the Diabetic Nephropathy Cohort in Singapore.
    Low S; Lim SC; Yeoh LY; Liu YL; Liu JJ; Fun S; Su C; Zhang X; Subramaniam T; Sum CF
    J Diabetes; 2017 Oct; 9(10):908-919. PubMed ID: 27935225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of chronic kidney disease on A1C in individuals being screened for diabetes.
    Shipman KE; Jawad M; Sullivan KM; Ford C; Gama R
    Prim Care Diabetes; 2015 Apr; 9(2):142-6. PubMed ID: 24893965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic and dual effects of glycated hemoglobin on estimated glomerular filtration rate in type 2 diabetic outpatients.
    Lee CL; Li TC; Lin SY; Wang JS; Lee IT; Tseng LN; Song YM; Tsai SF; Sheu WH
    Am J Nephrol; 2013; 38(1):19-26. PubMed ID: 23817017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How are patients with type 2 diabetes and renal disease monitored and managed? Insights from the observational OREDIA study.
    Penfornis A; Blicklé JF; Fiquet B; Quéré S; Dejager S
    Vasc Health Risk Manag; 2014; 10():341-52. PubMed ID: 24966684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.